fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
News

The Advantages of CAR T-Cell Therapy at Sheba Medical Center in Israel

CAR T-Cell Therapy
Not only is Sheba Medical Center one of only a handful of medical centers in the world to provide revolutionary CAR-T therapy, but there are many additional unique benefits to receiving the treatment at Sheba.

CAR cells must undergo extensive processing before they are ready to be administered to the patient. At Sheba, CARs are engineered in-house in a specialized laboratory. As a result, the entire process from lymphocyte collection to patient delivery only takes about 10 days. In contrast, many other hospitals use commercial CARs, which must be engineered abroad and shipped, taking months to become available. This delay allows the patient’s disease to progress further, which can also reduce the effectiveness of the body’s response to the CARs. Also, the shipping process compromises cell quality, as some cells die during the necessary freezing and thawing.

While commercial CARs are only approved for use in a few illnesses, Sheba’s CARs can be administered for a wide range of illnesses, including:

Sheba’s extensive experience with CAR T-cell therapy speaks louder than words. Under the expertise of Prof. Arnon Nagler, Director of the Hemato-Oncology Division and a world renowned specialist in the field, we have provided over 220 patients with CAR-T therapy, including about 60 children.

sheba's car-t
sheba's cars mob
Related
Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More